Transcoronary ablation for septal hypertrophy of hypertrophic obstructive cardiomyopathy

Surgical myectomy has been successfully used to treat patients with symptomatic hypertrophic obstructive cardiomyopathy [HOCM] for the last four decades, but is a major open heart surgery and is available only in selected centers. Transcoronary ablation of septal hypertrophy [TASH] is becoming the preferred approach, because of the novelty of the procedure, being. less traumatic, non surgical technique which is now supported by the evidence of, thousands of successfully treated patients all over the world We present our initial experience which to our knowledge is the first report from this region

Percutaneous coronary intervention [PCI] an emerging alternative to bypass surgery for unprotected left main artery disease

Both technological advances [including stenting and atherosclerotic techniques] and increased operator experience have led to the resurgence in percutaneous revascularization of unprotected left main disease over the past few years. We present our experience in two patients who undergone PCI for left main stem stenosis in different clinical settings

Primary angioplasty and stenting for cardiogenic shock supported by an intra-aortic balloon pump

The leading cause of death in patients hospitalised for acute myocardial infarction is cardiogenic shock. We report a young patient who presented with cardiorespiratory arrest and cardiogenic shock following acute anterior wall myocardial infarction. He was resuscitated by direct current cardioversion ventricular fibrillation and underwent intra-aortic balloon supported primary angioplasty and direct stenting